EDGAR Filing Documents for 0001104659-21-113607

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001104659-21-113607

Filing Date

2021-09-08

Accepted

2021-09-08 07:01:40

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B5	tm2127028d1_424b5.htm	424B5	485936
2	GRAPHIC	tm2127028d1_424b5img001.jpg	GRAPHIC	6464
3	GRAPHIC	tm2127028d1_424b5img002.jpg	GRAPHIC	5464
4	GRAPHIC	tm2127028d1_424b5img003.jpg	GRAPHIC	19537
5	GRAPHIC	tm2127028d1_424b5img004.jpg	GRAPHIC	14255
6	GRAPHIC	tm2127028d1_424b5img005.jpg	GRAPHIC	10918
	Complete submission text file	0001104659-21-113607.txt		565789

Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807

Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300

Osmotica Pharmaceuticals plc (Filer) CIK: 0001739426 (see all company filings)

IRS No.: 000000000
Type: 424B5 | Act: 33 | File No.: 333-236193 | Film No.: 211240628
SIC: 2834 Pharmaceutical Preparations